CL:0000034

Name:	stem cell
Namespace:	cell
Definition:	"A relatively undifferentiated cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells." [GOC:tfm, MESH:A.11.872]
Xrefs:	Expandlinks: FMA:63368

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0000144()

Children

is a:	CL:0000723 (somatic stem cell),CL:0002322 (embryonic stem cell)
derives from:	FF:0000255 (mouse inner hair stem cell sample),FF:0000626 (trophoblast cell line sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 10447-106F6
• 10568-108B1 (mesenchymal stem cell line:Hu5/E18)
• 10813-111B3 (normal embryonic palatal mesenchymal cell line:HEPM)
• 11214-116A8 (Mesenchymal stem cells - umbilical, donor0)
• 11217-116B2 (Mesenchymal stem cells - adipose, donor0)
• 11218-116B3 (Mesenchymal stem cells - hepatic, donor0)
• 11219-116B4 (Mesenchymal Stem Cells - Vertebral, donor1)
• 11229-116C5 (CD14+ monocyte derived endothelial progenitor cells, donor1)
• 11240-116D7 (Skeletal Muscle Satellite Cells, donor1)
• 11271-116H2 (Hair Follicle Dermal Papilla Cells, donor1)

... further results Mouse (Mus musculus)

• 10447-106F6
• 10568-108B1 (mesenchymal stem cell line:Hu5/E18)
• 10813-111B3 (normal embryonic palatal mesenchymal cell line:HEPM)
• 11214-116A8 (Mesenchymal stem cells - umbilical, donor0)
• 11217-116B2 (Mesenchymal stem cells - adipose, donor0)
• 11218-116B3 (Mesenchymal stem cells - hepatic, donor0)
• 11219-116B4 (Mesenchymal Stem Cells - Vertebral, donor1)
• 11229-116C5 (CD14+ monocyte derived endothelial progenitor cells, donor1)
• 11240-116D7 (Skeletal Muscle Satellite Cells, donor1)
• 11271-116H2 (Hair Follicle Dermal Papilla Cells, donor1)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000034 (stem cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
6.28e-50	FFCP PHASE1:Hg19::chr19:48828606..48828637,+	p2@EMP3
6.28e-50	FFCP PHASE2:Hg19::chr19:48828606..48828637,+	p2@EMP3
2.07e-48	FFCP PHASE1:Hg19::chr2:182322231..182322262,+	p2@ITGA4
2.07e-48	FFCP PHASE2:Hg19::chr2:182322231..182322262,+	p2@ITGA4
4.04e-48	FFCP PHASE2:Hg19::chr1:145096480..145096513,+	p2@SEC22B
4.04e-48	FFCP PHASE1:Hg19::chr1:145096480..145096513,+	p2@SEC22B
2.81e-45	FFCP PHASE1:Hg19::chr2:74781828..74781898,+	p1@DOK1
2.81e-45	FFCP PHASE2:Hg19::chr2:74781828..74781898,+	p1@DOK1
1.99e-44	FFCP PHASE2:Mm9::chr19:18807230..18807233,+	p1@ENSMUST00000083007
1.99e-44	FFCP PHASE1:Mm9::chr19:18807230..18807233,+	p1@ENSMUST00000083007
9.15e-44	FFCP PHASE1:Mm9::chr1:146456236..146456244,-	p1@ENSMUST00000157471
9.15e-44	FFCP PHASE2:Mm9::chr1:146456236..146456244,-	p1@ENSMUST00000157471
8.75e-43	FFCP PHASE1:Mm9::chr3:32910877..32910881,+	p1@ENSMUST00000122716
8.75e-43	FFCP PHASE2:Mm9::chr3:32910877..32910881,+	p1@ENSMUST00000122716
1.09e-41	FFCP PHASE1:Hg19::chr19:48828647..48828658,+	p3@EMP3
1.09e-41	FFCP PHASE2:Hg19::chr19:48828647..48828658,+	p3@EMP3
1.54e-41	FFCP PHASE2:Hg19::chr6:31704075..31704106,-	p2@CLIC1
1.54e-41	FFCP PHASE1:Hg19::chr6:31704075..31704106,-	p2@CLIC1
9.24e-41	FFCP PHASE2:Hg19::chr5:78281092..78281154,-	p1@ARSB
9.24e-41	FFCP PHASE1:Hg19::chr5:78281092..78281154,-	p1@ARSB
1.2e-40	FFCP PHASE1:Hg19::chr2:114647617..114647739,+	p1@ACTR3
1.2e-40	FFCP PHASE2:Hg19::chr2:114647617..114647739,+	p1@ACTR3
1.37e-39	FFCP PHASE1:Mm9::chr4:32085713..32085717,-	p1@ENSMUST00000122491
1.37e-39	FFCP PHASE2:Mm9::chr4:32085713..32085717,-	p1@ENSMUST00000122491
2.57e-39	FFCP PHASE1:Hg19::chr11:504446..504486,-	p4@RNH1
2.57e-39	FFCP PHASE2:Hg19::chr11:504446..504486,-	p4@RNH1
3.91e-39	FFCP PHASE1:Mm9::chr4:131826124..131826129,-	p1@ENSMUST00000104135
3.91e-39	FFCP PHASE2:Mm9::chr4:131826124..131826129,-	p1@ENSMUST00000104135
6.79e-39	FFCP PHASE1:Mm9::chr3:19460250..19460260,+	p1@ENSMUST00000083241
6.79e-39	FFCP PHASE2:Mm9::chr3:19460250..19460260,+	p1@ENSMUST00000083241
1.41e-38	FFCP PHASE2:Hg19::chr16:50300440..50300485,+	p1@ADCY7
1.41e-38	FFCP PHASE1:Hg19::chr16:50300440..50300485,+	p1@ADCY7
4.4e-38	FFCP PHASE2:Hg19::chr18:18691563..18691610,-	p4@ROCK1
4.4e-38	FFCP PHASE1:Hg19::chr18:18691563..18691610,-	p4@ROCK1
8.07e-38	FFCP PHASE2:Mm9::chr19:26334980..26334985,-	p1@ENSMUST00000122640
8.07e-38	FFCP PHASE1:Mm9::chr19:26334980..26334985,-	p1@ENSMUST00000122640
1.19e-37	FFCP PHASE2:Mm9::chr11:48596086..48596090,+	p@chr11:48596086..48596090, +
1.19e-37	FFCP PHASE1:Mm9::chr11:48596086..48596090,+	p@chr11:48596086..48596090, +
1.72e-37	FFCP PHASE2:Hg19::chr2:182322070..182322155,+	p1@ITGA4
1.72e-37	FFCP PHASE1:Hg19::chr2:182322070..182322155,+	p1@ITGA4
7.4e-37	FFCP PHASE1:Hg19::chr20:61584026..61584096,+	p1@SLC17A9
7.4e-37	FFCP PHASE2:Hg19::chr20:61584026..61584096,+	p1@SLC17A9
1.7e-36	FFCP PHASE2:Hg19::chr15:73076030..73076121,-	p1@ADPGK
1.7e-36	FFCP PHASE1:Hg19::chr15:73076030..73076121,-	p1@ADPGK
1.96e-36	FFCP PHASE1:Mm9::chr5:115939465..115939467,+	p1@ENSMUST00000102044
1.96e-36	FFCP PHASE2:Mm9::chr5:115939465..115939467,+	p1@ENSMUST00000102044
2.38e-36	FFCP PHASE2:Mm9::chr10:104477319..104477348,+	p1@ENSMUST00000082498
2.38e-36	FFCP PHASE1:Mm9::chr10:104477319..104477348,+	p1@ENSMUST00000082498
4.2e-36	FFCP PHASE2:Hg19::chr1:183604794..183604908,-	p1@ARPC5
4.2e-36	FFCP PHASE1:Hg19::chr1:183604794..183604908,-	p1@ARPC5
4.29e-36	FFCP PHASE1:Mm9::chr16:72264646..72264650,-	p@chr16:72264646..72264650, -
4.29e-36	FFCP PHASE2:Mm9::chr16:72264646..72264650,-	p@chr16:72264646..72264650, -
5.67e-36	FFCP PHASE2:Mm9::chr3:72925786..72925790,+	p@chr3:72925786..72925790, +
5.67e-36	FFCP PHASE1:Mm9::chr3:72925786..72925790,+	p@chr3:72925786..72925790, +
7.73e-36	FFCP PHASE2:Hg19::chr15:90358115..90358195,-	p3@ANPEP
7.73e-36	FFCP PHASE1:Hg19::chr15:90358115..90358195,-	p3@ANPEP
9.41e-36	FFCP PHASE2:Hg19::chr12:110888103..110888172,-	p1@ARPC3
9.41e-36	FFCP PHASE1:Hg19::chr12:110888103..110888172,-	p1@ARPC3
1.48e-35	FFCP PHASE2:Mm9::chr14:106660467..106660471,-	p1@ENSMUST00000083259
1.48e-35	FFCP PHASE1:Mm9::chr14:106660467..106660471,-	p1@ENSMUST00000083259
1.52e-35	FFCP PHASE2:Hg19::chr1:145096514..145096528,+	p3@SEC22B
1.52e-35	FFCP PHASE1:Hg19::chr1:145096514..145096528,+	p3@SEC22B
3.22e-35	FFCP PHASE1:Mm9::chr11:68886926..68886931,+	p1@ENSMUST00000082965
3.22e-35	FFCP PHASE2:Mm9::chr11:68886926..68886931,+	p1@ENSMUST00000082965
3.55e-35	FFCP PHASE1:Hg19::chr12:75874580..75874611,+	p2@GLIPR1
3.55e-35	FFCP PHASE2:Hg19::chr12:75874580..75874611,+	p2@GLIPR1
4.93e-35	FFCP PHASE1:Hg19::chr2:102091566..102091581,-	p1@RFX8
4.93e-35	FFCP PHASE2:Hg19::chr2:102091566..102091581,-	p1@RFX8
1.03e-34	FFCP PHASE2:Hg19::chr1:46016703..46016755,+	p2@AKR1A1
1.03e-34	FFCP PHASE1:Hg19::chr1:46016703..46016755,+	p2@AKR1A1
2.43e-34	FFCP PHASE2:Hg19::chr11:504867..504925,-	p3@RNH1
2.43e-34	FFCP PHASE1:Hg19::chr11:504867..504925,-	p3@RNH1
2.47e-34	FFCP PHASE1:Hg19::chr9:35112376..35112395,-	p@chr9:35112376..35112395, -
2.47e-34	FFCP PHASE2:Hg19::chr9:35112376..35112395,-	p@chr9:35112376..35112395, -
4.52e-34	FFCP PHASE2:Hg19::chr9:101984577..101984616,+	p2@SEC61B
4.52e-34	FFCP PHASE1:Hg19::chr9:101984577..101984616,+	p2@SEC61B
4.61e-34	FFCP PHASE1:Hg19::chr15:90358048..90358103,-	p1@ANPEP
4.61e-34	FFCP PHASE2:Hg19::chr15:90358048..90358103,-	p1@ANPEP
5.21e-34	FFCP PHASE2:Hg19::chrX:48432892..48432916,+	p1@RBM3
5.21e-34	FFCP PHASE1:Hg19::chrX:48432892..48432916,+	p1@RBM3
1.84e-33	FFCP PHASE2:Hg19::chr11:504942..504959,-	p5@RNH1
1.84e-33	FFCP PHASE1:Hg19::chr11:504942..504959,-	p5@RNH1
2.03e-33	FFCP PHASE2:Hg19::chr21:26934434..26934452,+	p1@MIR155HG
2.03e-33	FFCP PHASE1:Hg19::chr21:26934434..26934452,+	p1@MIR155HG
2.43e-33	FFCP PHASE2:Hg19::chr10:17271909..17272033,-	p1@uc001iot.1
2.43e-33	FFCP PHASE1:Hg19::chr10:17271909..17272033,-	p1@uc001iot.1
2.52e-33	FFCP PHASE1:Hg19::chr2:192542577..192542595,-	p@chr2:192542577..192542595, -
2.52e-33	FFCP PHASE2:Hg19::chr2:192542577..192542595,-	p@chr2:192542577..192542595, -
5.08e-33	FFCP PHASE2:Mm9::chr4:33051742..33051793,+	p1@ENSMUST00000077575
5.08e-33	FFCP PHASE1:Mm9::chr4:33051742..33051793,+	p1@ENSMUST00000077575
5.11e-33	FFCP PHASE1:Hg19::chr11:58345226..58345262,+	p@chr11:58345226..58345262, +
5.11e-33	FFCP PHASE2:Hg19::chr11:58345226..58345262,+	p@chr11:58345226..58345262, +
7.22e-33	FFCP PHASE2:Hg19::chr1:20987936..20987969,-	p2@DDOST
7.22e-33	FFCP PHASE1:Hg19::chr1:20987936..20987969,-	p2@DDOST
8.55e-33	FFCP PHASE1:Hg19::chr3:50378235..50378286,-	p2@RASSF1
8.55e-33	FFCP PHASE2:Hg19::chr3:50378235..50378286,-	p2@RASSF1
1.14e-32	FFCP PHASE2:Hg19::chr4:103747996..103748022,-	p4@UBE2D3
1.14e-32	FFCP PHASE1:Hg19::chr4:103747996..103748022,-	p4@UBE2D3
1.35e-32	FFCP PHASE2:Mm9::chr11:68834407..68834410,+	p@chr11:68834407..68834410, +
1.35e-32	FFCP PHASE1:Mm9::chr11:68834407..68834410,+	p@chr11:68834407..68834410, +

Showing 1 to 100 of 100 entries